CellSource Co., Ltd.

49
Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3423580004
JPY
481.00
-1 (-0.21%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
CellSource Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Oct'24
Oct'23
Oct'22
Oct'21
Oct'20
Oct'19
No of Months
12
12
12
12
12
12
Profit Before Tax
294.00
1,239.00
1,583.00
1,006.00
412.00
303.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
333.00
195.00
-344.00
-36.00
-76.00
-36.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
591.00
846.00
847.00
898.00
330.00
195.00
Cash Flow from Investing Activities
-614.00
-624.00
-169.00
-256.00
-57.00
-107.00
Cash Flow from Financing Activities
-437.00
1,449.00
14.00
9.00
152.00
993.00
Net Cash Inflow / Outflow
-460.00
1,657.00
714.00
652.00
423.00
1,080.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
-14.00
21.00
0.00
-1.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of CellSource Co., Ltd.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Profit Before Tax
294.941
3544.987
-3,250.00
-91.68%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
333.501
1241.465
-908.00
-73.14%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
591.723
4500.06
-3,909.00
-86.85%
Cash Flow from Investing Activities
-614.961
-2233.51
1,619.00
72.47%
Cash Flow from Financing Activities
-437.244
-849.533
412.00
48.53%
Net Cash Inflow / Outflow
-460.106
1360.836
-1,820.00
-133.81%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.376
-56.181
56.00
100.67%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Oct'24
stock-summary

YoY Growth in year ended Oct 2024 is -30.11% vs -0.11% in Oct 2023

Oct'24
Oct'23
Change(%)
Cash Flow from Operating Activities
591.72
846.69
-30.11%